Folded protein with molecular-dynamics trajectories, electrostatic surface regions, and data-driven prediction cues
Next-generation ADC design + discovery · Since 2020

Designing what
medicine needs next.

We unite generative AI, antibody engineering, and conjugate design to develop next-generation, differentiated ADCs.

Explore our technology Explore applications
South San FranciscoDiscovery stage

Built to move discovery
forward with purpose

PlatformAI-guided designExplore broader molecular possibilities
ExpertiseIntegrated ADC designConnect computation, conjugate science, and biology
MissionPatients firstAdvance meaningful therapeutic ideas
The MarWell platform

From vast possibility
to viable medicine.

Conventional discovery explores ADC components in a vast, interdependent design space. Our platform learns the rules of therapeutic function—then generates integrated candidates built to meet the brief.

MarWell
Generate™
01

Define

Translate the product profile into measurable molecular objectives.

02

Generate

Explore novel ADC designs and antibody sequences with purpose-built AI models.

03

Prioritize

Score candidates across binding, specificity and developability.

04

Validate

Close the loop with experiments that strengthen every design cycle.

⌁

Multi-parameter by design

Optimize biological activity and drug-like properties together—not as an afterthought.

◇

Built for novel biology

Go beyond sequence matching to create differentiated candidates for demanding targets.

↻

Learning in every cycle

Experimental evidence feeds back into the system, improving the next generation of designs.

Our work

A focused path
from design
to impact.

We apply generative AI to important challenges in ADC discovery and design. Our work is guided by clear therapeutic goals, disciplined validation, and the needs of patients.

FoundationGenerative AI
ExpertiseADC design + antibody engineering
DirectionNext-generation ADCs
Explore a partnership
Molecular visualization of a protein binding interface
Generate
Learn
Conceptual protein interface
Why MarWell
“The next generation of ADCs will not simply be found. They will be designed.”

Since 2020, MarWell Bio has been forging new frontiers in targeted drug design and discovery with generative AI. We are building a future where differentiated ADCs begin with intention—not chance.

01 · Purpose-built AI02 · Translational rigor03 · Patient-led ambition
Partner with MarWell Bio

Let’s design the
next breakthrough.

We’re building relationships with scientific, clinical and strategic partners who share our ambition for better cancer medicines.

Start a conversation